Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression

Bibliographic Data

ID9022326
AuthorsRosalind Watts (Imperial College London, London, UK, corresponding author), Camilla Day (Imperial College London, London, UK), Jacob Krzanowski (0000-0001-7749-5716, Imperial College London, London, UK), David Nutt (0000-0002-6423-9411, Imperial College London, London, UK), Robin Carhart-Harris (Imperial College London, London, UK), Robin Carhart‐Harris (Imperial College London)
Year2017
Volume57
Issue5
Pages520-564
Publication date2017-06-19
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Humanistic Psychology (JOURNAL)
Journal identifiersISSN: 0022-1678 • E-ISSN: 1552-650X
PublisherSAGE Publishing (PUBLISHER • US)
DOI10.1177/0022167817709585
OpenAlexW2644260506
LanguageEN
Citations received130
References cited41

Objective: To identify patients’ perceptions of the value of psilocybin as a treatment for depression. Method: Twenty patients enrolled in an open-label trial of psilocybin for treatment-resistant depression participated in a semistructured interview at 6-month follow-up. Thematic analysis was used to identify patients’ experiences of the treatment and how it compared with previous treatments. Results: Two main change processes were identified in relation to the treatment. The first concerned change from disconnection (from self, others, and world) to connection, and the second concerned change from avoidance (of emotion) to acceptance. A third theme concerned comparison between psilocybin and conventional treatments. Patients reported that medications and some short-term talking therapies tended to reinforce their sense of disconnection and avoidance, whereas treatment with psilocybin encouraged connection and acceptance. Conclusions: These results suggest that psilocybin treatment for depression may work via paradigmatically novel means, antithetical to antidepressant medications, and some short-term talking therapies

Antidepressant · Cognition · Depression (economics · Depressive symptoms · Disconnection · Hallucinogen · Perception · Psilocybin · Psychiatry · Psychotherapist · Chemical synthesis and alkaloids · Clinical Psychology · Complementary and Alternative Medicine Studies · Psychedelics and Drug Studies · Psychology

  • Embodied Transformation

    Open Access•Zinet Ritschel, Brady Wagoner•Integrative Psychological and…•2026

  • The potential of psilocybin use to enhance well-being in healthy individuals – A scoping review

    Open Access•Lennart Wiepking, Ed de Bruin et al.•Journal of Psychedelic Studies•2023

  • Psilocybin with psychological support for treatment-resistant depression

    Open Access•Robin Carhart‐Harris, R L Carhart-Harris et al.•Psychopharmacology•2018

  • Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

    Open Access•Leor Roseman, David Nutt et al.•Frontiers in Pharmacology•2018

  • Long-term effects of psychedelic drugs

    Open Access•Jacob S Aday, Cayla M Mitzkovitz et al.•Neuroscience & Biobehavioral…•2020

  • Emotional breakthrough and psychedelics

    Open Access•Leor Roseman, Eline Haijen et al.•Journal of Psychopharmacology•2019

  • Psychedelic therapy for smoking cessation

    Open Access•T Noorani, Albert Garcia-Romeu et al.•Journal of Psychopharmacology•2018

  • Rebus and the Anarchic Brain

    Open Access•Robin Carhart‐Harris, R L Carhart-Harris et al.•Pharmacological Reviews•2019

  • Psychedelics and the essential importance of context

    Open Access•Robin L Carhart-Harris, Leor Roseman et al.•Journal of Psychopharmacology•2018

  • From fragmentation to communion

    Open Access•Maria Fernanda Gebara•Journal of Psychedelic Studies•2026

  • Psychedelics and the Ontology of Work

    Jeffrey Overall•Journal of Management,…•2026

  • The library is open

    Open Access•Amy Bartlett, Challian Christ et al.•Frontiers in Public Health•2024

  • Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico

    Open Access•Lawrence Leeman, Maya Armstrong et al.•Frontiers in Public Health•2026

  • Awe as a Pathway to Mental and Physical Health

    Open Access•Maria Monroy, Dacher Keltner•Perspectives on Psychological…•2023

  • Mental disorder and its treatment as a transformative experience

    Open Access•Daniel Villiger•Phenomenology and the Cognitive…•2025

  • Psychedelic-assisted psychotherapy for the treatment of major depression

    Open Access•Riccardo Miceli Mcmillan, Christopher F C Jordens•Medicine Health Care and Philosophy•2022

  • “You can only take your clients as far as you’ve been yourself”

    Open Access•Jordan J Negrine, Stephen J Bright et al.•Drugs Education Prevention and…•2026

  • Existential feelings as a phenomenological framework for psychedelic therapy

    Open Access•Floris B Tijhuis, Sabrina Coninx et al.•Philosophical Psychology•2025

  • Psychedelic experiences in psychedelic-assisted therapy for depression

    Open Access•Umair Khan, Uzair Khan•Philosophical Psychology•2025

  • Psychedelics and environmental virtues

    Nin Kirkham, C Letheby•Philosophical Psychology•2024

  • Psychedelic therapies and belief change

    Maximiliano Zeller•Philosophical Psychology•2025

  • Online social pain reliever

    Open Access•Wenying Yuan, Tingjun Guo et al.•Computers in Human Behavior•2024

  • With great power comes great vulnerability

    Daniel Villiger, Manuel Trachsel•Journal of Medical Ethics•2023

  • Ethics and ego dissolution

    William Smith, Dominic Sisti•Journal of Medical Ethics•2021

  • Intention-Setting Among Recreational Psychedelic Users

    Francis Low, M Earleywine•Journal of Psychoactive Drugs•2026

  • Philosophical theorising about the rumination of depression

    Open Access•Victor Lange•Mind & Language•2026

  • The Impact of Awe on Existential Isolation

    Open Access•Megan Edwards, Peter J Helm et al.•Personality and Social Psychology…•2024

  • Evidencias y perspectivas del potencial antidepresivo del “alcaloide mágico” psilocibina

    Open Access•María Marcela Velásquez Toledo•Cultura y Droga•2023

  • Peer cybervictimization and cyberaggression as a function of developmental stage during adolescence

    Open Access•Priscila Pérez-Rodríguez, Juan M Machimbarrena et al.•Acta Psychologica•2024

  • Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic

    Open Access•Zuzana Postránecká, Matyáš Lucký et al.•Journal of Psychedelic Studies•2026

  • Restructuring insight

    Open Access•Kadi Tulver, Karl Kristjan Kaup et al.•Consciousness and Cognition•2023

  • Is music a drug? How music listening may trigger neurochemical responses in the brain

    Open Access•Mark Reybrouck, Edith Van Dyck•Musicae Scientiae•2024

  • Psychoactive Substances in Daoist Practice

    Open Access•Qiongke Geng•Religions•2026

  • Resetting the default in the psychedelic renaissance

    Open Access•Sujit Thomas•BioSocieties•2026

  • Transient epistemic vulnerability and normative capture

    Maximiliano Zeller•Philosophical Psychology•2026

  • Ancient Roots of Today’s Emerging Renaissance in Psychedelic Medicine

    Open Access•Daniel R George, Ryan Hanson et al.•Culture Medicine and Psychiatry•2022

  • Memory, trauma, and self

    Open Access•J R Rose•Journal of Psychedelic Studies•2024

  • Perceptions of psychedelic personality change, determinants of use, setting and drug moderation

    Open Access•Brandon Wei, Chelsea E Sleep et al.•Journal of Psychedelic Studies•2023

  • Non-hallucinogenic psychedelic psychotherapy

    Open Access•Joanna Pashdag•Journal of Psychedelic Studies•2024

  • Psychedelic therapy as reality transformation

    Open Access•M Sanchez Petrement•Journal of Psychedelic Studies•2023

  • Psychedelic intimacy

    Open Access•Jonas J Neubert, Katie Anderson et al.•Journal of Psychedelic Studies•2024

  • Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms

    Open Access•A S Machado Ferreira, Sharon Martindale et al.•Journal of Psychedelic Studies•2024

  • Participant experiences of icaros (Amazonian curative songs) during a traditional medicine ceremony at the Takiwasi Center, Peru

    Open Access•Martin Sherwin, Fabio Friso et al.•Journal of Psychedelic Studies•2025

  • Integration of personal psychedelic experiences into clinical practice

    Open Access•Nir Tadmor, Daniel Halperin et al.•Journal of Psychedelic Studies•2025

  • Conceptualizing your new reality

    Open Access•C Quasti, Dominic Sisti•Journal of Psychedelic Studies•2024

  • Psychedelic-assisted therapy for death acceptance in terminal illness

    Open Access•Hannah Whitmore, B L Anderson et al.•Journal of Psychedelic Studies•2026

  • Becoming a Psychedelic User

    Open Access•J R Rose•Sociology Compass•2025

  • Psychedelics, Sociality, and Human Evolution

    Open Access•José M Rodríguez Arce, Michael James Winkelman•Frontiers in Psychology•2021

  • Psychedelic assemblages

    Open Access•Joshua Falcon•Critique of Anthropology•2025

  • Effects of awe on self-transcendence

    Open Access•Chun‐xia Zhao, Chenxiao Zhao et al.•Journal of Experimental Social…•2025

  • Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder

    Open Access•Richard J Zeifman, A C Wagner•Journal of Contextual Behavioral…•2019

  • The centrality of sense of self in psychological flexibility processes

    Open Access•Steven C Hayes, Stu Law et al.•Journal of Contextual Behavioral…•2019

  • The use of the psychological flexibility model to support psychedelic assisted therapy

    Open Access•Rosalind Watts, Jason B Luoma•Journal of Contextual Behavioral…•2019

  • Psychedelics and psychological flexibility – Results of a prospective web-survey using the Acceptance and Action Questionnaire II

    Open Access•James B Close, Eline C Hajien et al.•Journal of Contextual Behavioral…•2020

  • Toward a contextual psychedelic-assisted therapy

    Open Access•Jason B Luoma, Pablo Sabucedo et al.•Journal of Contextual Behavioral…•2019

  • The effects of psilocybin on psychological distress in cancer patients

    Open Access•Reza Moshfeghinia, Sara Mostafavi et al.•BMC Psychology•2026

  • Self-Transcendent Positive Emotions as a Potential Mechanism Underpinning the Effects of Meaningful Psychedelic Experiences on Connectedness to Nature

    Open Access•Katie Newton, Sam G Moreton•Ecopsychology•2022

  • Psychedelic substitution

    Open Access•Nicolas G Glynos, Jacob S Aday et al.•Frontiers in Psychiatry•2024

  • Psychedelic therapy

    Open Access•Ronit Kishon, Yael M Cycowicz•Frontiers in Psychiatry•2025

  • Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography

    Open Access•Winston De La Haye, Geoffrey Walcott et al.•Frontiers in Psychiatry•2023

  • Psychedelic replications in virtual reality and their potential as a therapeutic instrument

    Open Access•Karl Kristjan Kaup, Madis Vasser et al.•Frontiers in Psychiatry•2023

  • Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial

    Open Access•T H W Ching, B Stahnke et al.•Frontiers in Psychiatry•2025

  • Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential

    Open Access•Rita Kočárová, Jiřı́horáček et al.•Frontiers in Psychiatry•2021

  • Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder

    Open Access•Keith G Heinzerling, Karina Sergi et al.•Frontiers in Psychiatry•2023

  • Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample

    Open Access•Keri Mans, Hannes Kettner et al.•Frontiers in Psychiatry•2021

  • Self-Medication for Chronic Pain Using Classic Psychedelics

    Open Access•Julia Bornemann, James B Close et al.•Frontiers in Psychiatry•2021

  • Learning to Let Go

    Open Access•Max Wolff, Ricarda Evens et al.•Frontiers in Psychiatry•2020

  • How Psychedelic-Assisted Treatment Works in the Bayesian Brain

    Open Access•Daniel Villiger•Frontiers in Psychiatry•2022

  • Decreases in State and Trait Anxiety Post-psilocybin

    Open Access•Maggie Kiraga, Maggie Kamila Kiraga et al.•Frontiers in Psychiatry•2022

  • Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression

    Open Access•Joost J Breeksema, Alistair Niemeijer et al.•Frontiers in Psychiatry•2022

  • Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings

    Open Access•Ana María Ortiz Bernal, Charles L Raison et al.•Frontiers in Psychiatry•2022

  • A Spectrum of Selves Reinforced in Multilevel Coherence

    Open Access•Henry J Whitfield•Frontiers in Psychiatry•2021

  • This Is Something That Changed My Life”

    Open Access•Özden Merve Mollaahmetoğlu, Johanna Keeler et al.•Frontiers in Psychiatry•2021

  • How psychedelic-assisted therapy works for depression

    Open Access•Lauren Johansen, Paul Liknaitzky et al.•Frontiers in Psychiatry•2023

  • Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation

    Open Access•Richard J Zeifman, A C Wagner et al.•Frontiers in Psychiatry•2020

  • Moral Psychopharmacology Needs Moral Inquiry

    Open Access•N Langlitz, Erika Dyck et al.•Frontiers in Psychiatry•2021

  • Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample

    Open Access•Christin Mellner, Micael Dahlén et al.•International Journal of…•2022

  • Classic Psychedelics and Human–Animal Relations

    Open Access•Elin Pöllänen, Walter Osika et al.•International Journal of…•2022

  • From Egoism to Ecoism

    Open Access•Hannes Kettner, Gandy et al.•International Journal of…•2019

  • Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder

    Open Access•Brandon Wei, Leor Roseman et al.•International Journal of Mental…•2024

  • Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing

    Open Access•Jussi Jylkkä, Hilla Väyrynen et al.•Consciousness and Cognition•2025

  • Microdosing psychedelics

    Open Access•Toby Lea, Nicole Amada et al.•International Journal of Drug…•2020

  • Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting

    Open Access•Elmiro Argento, Elena Argento et al.•International Journal of Drug…•2022

  • Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences

    Open Access•Michelle Olofsson, Walter Osika et al.•International Journal of Drug…•2026

  • Acute Subjective Effects of Psychedelics within and Beyond Weird Contexts

    Mariolina Graziosi, Manvir Singh et al.•Journal of Psychoactive Drugs•2023

  • Psychedelic-Assisted Group Therapy

    Alexander Trope, Brian Anderson et al.•Journal of Psychoactive Drugs•2019

  • Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy

    Open Access•Sascha Thal, Michelle Wieberneit et al.•Journal of Humanistic Psychology•2023

  • Meaningful Psychedelic Experiences Predict Increased Moral Expansiveness

    Open Access•Will Olteanu, Sam G Moreton•Journal of Psychoactive Drugs•2025

  • Therapeutic-Like Context and Relational Support During Psychedelic Use Moderate Links Among Stress, Challenging Experiences, and Psychological Outcomes

    Open Access•Aaron D Cherniak, Pehr Granqvist et al.•Journal of Psychoactive Drugs•2026

  • Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals

    Ana María Ortiz Bernal, Charles L Raison et al.•Journal of Psychoactive Drugs•2025

  • A Qualitative Analysis of First-Hand Accounts of Diphenhydramine Misuse Available on YouTube

    Haley Maria Dourron, H Copes et al.•Journal of Psychoactive Drugs•2023

  • Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness

    Maha N Mian, Brianna R Altman et al.•Journal of Psychoactive Drugs•2019

  • Self-Care Practices with Psychedelics – A Qualitative Study of Users’ Perspectives

    Carla Soares, Ângela Leite et al.•Journal of Psychoactive Drugs•2022

  • Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction

    William P Barone, William Barone et al.•Journal of Psychoactive Drugs•2019

  • Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States

    Open Access•A K Davis, Gabrielle Agin-Liebes et al.•Journal of Psychoactive Drugs•2021

  • Examining Normative Male Alexithymia in Men Reporting Psychedelic and Non-Psychedelic Self-Transcendent Experiences

    Open Access•Shaun Sleightholm, Catherine O'Neill•Psychological Reports•2026

  • I can objectively view my trauma without feeling like I'm there”

    Open Access•Emma Yuanqi Gu, Natalia M Irvine et al.•Journal of Psychedelic Studies•2026

  • Historicizing psychedelics

    Open Access•M Sanchez Petrement•Frontiers in Sociology•2023

  • Designing Consciousness

    Open Access•Joshua Falcon•Design and Culture•2020

  • Psychedelic Science of Spirituality and Religion

    Open Access•Aaron D Cherniak, Joel Gruneau Brulin et al.•International Journal for the…•2022

  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer

    Open Access•Roland R Griffiths, Matthew W Johnson et al.•Journal of Psychopharmacology•2016

  • Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

    Open Access•Robin Carhart‐Harris, Robin L Carhart-Harris et al.•Proceedings of the National…•2012

  • Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

    Open Access•Katherine A Maclean, Matthew W Johnson et al.•Journal of Psychopharmacology•2011

  • Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions

    Open Access•Simon Lewin, Claire Glenton et al.•BMJ•2009

  • Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

    Charles S Grob, Alicia Danforth et al.•Archives of General Psychiatry•2011

  • A Randomized Controlled Effectiveness Trial of Acceptance and Commitment Therapy and Cognitive Therapy for Anxiety and Depression

    Open Access•Evan M Forman, Evan Forman et al.•Behavior Modification•2007

  • Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer

    Open Access•Stephen Ro, Stephen Ross et al.•Journal of Psychopharmacology•2016

  • Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression

    Open Access•Flávia de Lima Osório, Rafael Faria Sanches et al.•Brazilian Journal of Psychiatry•2015

  • LSD-assisted psychotherapy for anxiety associated with a life-threatening disease

    Open Access•Peter Gasser, Katharina Kirchner et al.•Journal of Psychopharmacology•2015

  • Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder

    Francisco Moreno, Francisco A Moreno et al.•The Journal of Clinical Psychiatry•2006

  • How important are the common factors in psychotherapy? An update

    Open Access•Bruce E Wampold•World Psychiatry•2015

  • Long-term follow-up of psilocybin-facilitated smoking cessation

    Matthew W Johnson, Albert Garcia-Romeu et al.•The American Journal of Drug and…•2017

  • Psilocybin with psychological support for treatment-resistant depression

    Open Access•Robin L Carhart-Harris, Mark Bolstridge et al.•The Lancet Psychiatry•2016

  • Psychedelics

    Open Access•David E Nichols•Pharmacological Reviews•2016

  • Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

    Open Access•Peter Gasser, Dominique Holstein et al.•The Journal of Nervous and Mental…•2014

  • Psilocybin-assisted treatment for alcohol dependence

    Open Access•Michael P Bogenschutz, Alyssa A Forcehimes et al.•Journal of Psychopharmacology•2015

  • Client-centered therapy; its current practice, implications, and theory

    Dwight W Miles•Psychological Bulletin•1952

  • Triangulation, Respondent Validation, and Democratic Participation in Mixed Methods Research

    Open Access•Harry Torrance•Journal of Mixed Methods Research•2012

  • Patient Experiences of Psilocybin-Assisted Psychotherapy

    Open Access•Alexander Belser, Alexander B Belser et al.•Journal of Humanistic Psychology•2017

  • Successful Qualitative Research

    Virginia Braun•Successful Qualitative Research•2013

Unique citing works130
Citations per year16,25
Citation span2018 - 2026 (9)
Citation velocitycurrent
Highly citedYes
Citation typesNeutral: 128

Tools

Open DOISci-Hub
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae